A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
Pfizer
Pfizer
RemeGen Co., Ltd.
Pfizer
Amgen
University of Utah
Fate Therapeutics
Rutgers, The State University of New Jersey
AbbVie
H. Lee Moffitt Cancer Center and Research Institute
BioNTech SE
Nurix Therapeutics, Inc.
First Affiliated Hospital of Zhejiang University
Peking University Cancer Hospital & Institute
Shanghai Junshi Bioscience Co., Ltd.
DEKA Biosciences
AstraZeneca
Jazz Pharmaceuticals
Eli Lilly and Company
Canadian Cancer Trials Group
Canadian Cancer Trials Group
OHSU Knight Cancer Institute
Novartis
Calithera Biosciences, Inc
Bristol-Myers Squibb
Emory University
Daiichi Sankyo
Gilead Sciences
Incyte Corporation
Tracon Pharmaceuticals Inc.
AbbVie
Abramson Cancer Center at Penn Medicine
West Virginia University
Alliance for Clinical Trials in Oncology
Washington University School of Medicine
AbbVie
GlaxoSmithKline
EMD Serono
Milton S. Hershey Medical Center
NewVac LLC
M.D. Anderson Cancer Center
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
Virginia Commonwealth University
Brown University
National Cancer Institute (NCI)
Biogen
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sanofi